Indication
Solid Tumor Cancers
2 clinical trials
2 products
Clinical trial
Phase I/II Study of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma, and Other GD2(+) Solid TumorsStatus: Terminated, Estimated PCD: 2021-10-20
Product
3F8 Bispecific AntibodyClinical trial
A Phase 2 Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersStatus: Recruiting, Estimated PCD: 2025-02-01
Product
Ado-Trastuzumab Emtansine